IDEAYA Biosciences (IDYA) Change in Account Payables (2018 - 2026)

IDEAYA Biosciences has disclosed Change in Account Payables across 9 years of filings, most recently posting $3.0 million for Q1 2026.

• Change in Account Payables for Q1 2026 came in at $3.0 million, up 11.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (down 73.66% YoY), and the FY2025 annual result was $2.7 million, down 67.43% from the prior year.
• Change in Account Payables came in at $3.0 million for Q1 2026 at IDEAYA Biosciences, up from -$858000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $9.7 million in Q2 2024 to a low of -$3.9 million in Q3 2024.
• The 5-year median for Change in Account Payables is $863000.0 (2022), against an average of $1.1 million.
• Across the five-year window, Change in Account Payables soared 5771.43% in 2022 and slumped 3675.0% in 2024, its largest moves.
• IDEAYA Biosciences' Change in Account Payables stood at $397000.0 in 2022, then surged by 339.55% to $1.7 million in 2023, then jumped by 70.54% to $3.0 million in 2024, then slumped by 128.83% to -$858000.0 in 2025, then jumped by 455.48% to $3.0 million in 2026.
• The last three Change in Account Payables figures came in at $3.0 million (Q1 2026), -$858000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.